Schisandrin C Improves Chronic Stress-Induced Dyslipidemia in Mice by Regulating Pyroptosis and Autophagy Levels
Journal of Microbiology and Biotechnology · 2025
DOI: 10.4014/jmb.2501.01041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, 2025. Verfasst von Yuling Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Guilin Medical University, Guilin, P.R. China. Hauptthemen laut MEDLINE: Lignans, Dyslipidemias, Autophagy, Pyroptosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Guangxi Natural Science Foundation, Guangxi Science and Technology Base and Special Talents.
Abstract (Originalsprache)
Chronic stress emerges as a significant risk factor for metabolic disorders, including hyperlipidemia and fatty liver disease. Schisandrin C (SchC), an essential component of Schisandra chinensis lignans, is known to possess lipid-lowering and liver-protective properties. However, the precise mechanisms underlying its action remain incompletely understood. We hypothesized that SchC exerts a protective effect on chronic stress-induced dyslipidemia in mice by modulating hepatic autophagy and pyroptosis. In this study, a dual model was established for 12 weeks, combining chronic stress with a high-fat diet (HFD). SchC or simvastatin were given respectively starting at week 10. Blood, epididymal white adipose tissue and liver were collected for further analysis. Behavioral tests and lipid levels showed that the dual model construction of HFD and chronic stress used in this study was successful in placing mice in a stressful environment and triggering dyslipidemia. SchC intervention effectively impeded the accumulation of eWAT and reduced the increased lipid levels in mice induced by chronic stress. The expression levels of the pyroptosis marker Caspase-1 and other inflammatory factors NLRP3, IL-1β, and IL-18 were significantly reduced in the liver tissues of chronically stressed mice under SchC treatment. Additionally, SchC significantly reduced expression levels of autophagy-related factors such as Beclin-1, the LC3-B/A ratio, P62, and markers related to the autophagy pathway (PI3K/AKT/mTOR). SchC effectively improves dyslipidemia through various pathways including inhibiting the PI3K/AKT/mTOR pathway, promoting autophagy, reducing pyroptosis. This provides a solid theoretical foundation for the clinical application of SchC in the treatment of dyslipidemia and related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Guilin Medical University, Guilin, P.R. China.
- Key Cultivation Laboratory of Life Cycle Health Care Research, Guilin, P.R. China.
- Guangxi Key Laboratory of Environmental Exposomics and Whole Life Cycle Health, Guilin, P.R. China.
- General Practice Department, Affiliated Hospital of Guilin Medical University, Guilin, P.R. China.
- Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, P.R. China.
- Medical Information Management, School of Humanities and Management, Guilin Medical University, Guilin, P.R. China.
Förderung
- National Natural Science Foundation of China
- Guangxi Natural Science Foundation
- Guangxi Science and Technology Base and Special Talents
- Zhongshan Hospital affiliated to Fudan University
- Shanghai Municipal Key Clinicial Specialty
- Guangxi Key Laboratory of Liver Injury and Repair
- Shanghai Top Priority research center
- First Affiliated Hospital of Guangxi Medical University
Zitieren
APA
Liu, Y., Lu, W., Huang, Y., Xu, C., Wu, W., Zhang, Z., Zhang, Y., Li, S., Wu, G., Wang, D., Xu, Y., Zheng, M., Wu, H., & Hu, L. (2025). Schisandrin C Improves Chronic Stress-Induced Dyslipidemia in Mice by Regulating Pyroptosis and Autophagy Levels. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2501.01041
Vancouver
Liu Y, Lu W, Huang Y, Xu C, Wu W, Zhang Z, et al. Schisandrin C Improves Chronic Stress-Induced Dyslipidemia in Mice by Regulating Pyroptosis and Autophagy Levels. Journal of Microbiology and Biotechnology. 2025. doi:10.4014/jmb.2501.01041
BibTeX
@article{Liu2025,
author = {Liu, Yuling and Lu, Wenjun and Huang, Yue and Xu, Chaozhi and Wu, Wanhua and Zhang, Zongyi and Zhang, Yulin and Li, Shanqian and Wu, Guixian and Wang, Doudou and Xu, Yao and Zheng, Meimei and Wu, Hongxian and Hu, Lina},
title = {Schisandrin C Improves Chronic Stress-Induced Dyslipidemia in Mice by Regulating Pyroptosis and Autophagy Levels},
journal = {Journal of Microbiology and Biotechnology},
year = {2025},
doi = {10.4014/jmb.2501.01041}
}
EUVIMED